BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 17, 2006
View Archived Issues
Preclinical and clinical results for ceftaroline reported at ICAAC
Read More
Hsp90 inhibition activates Fas apoptotic pathway in cultured motor neurons
Read More
Talabostat upregulates innate and acquired immunity against cancer cells
Read More
Phase I/II study of Cardeva begins dosing
Read More
Indian approval for glioblastoma trial of Cotara
Read More
Endo acquires RxKinetix
Read More
FDA requests additional data to support use of Fuzeon with needle-free device
Read More
Enrollment completed in skin cancer pilot study of PEP-005 Topical
Read More
TPM-02/insulin delivers insulin through skin in phase I trial
Read More
Gene Logic to seek alternative development paths for Lilly drug candidates
Read More
Ambrilia licenses HIV/AIDS protease inhibitor program rights to Merck & Co.
Read More
End-of-phase II meeting requested for Diamyd
Read More
SPA reached for phase II study of M-Vax in metastatic melanoma
Read More
EKR Therapeutics acquires North American rights for Gelclair
Read More
Dosing completed in twin phase III studies of PreHistin
Read More
Fresenius to acquire phosphate binder business from Nabi
Read More
Multispan and Medarex sign licensing agreement
Read More
Immune Response updates recent clinical progress
Read More
Recent patents disclose novel antiinfective agents
Read More
Recent Novartis and GSK patents impart new therapeutics for respiratory disorders
Read More
New agents for depression, psychosis, sleep disorders, etc., patented
Read More
AMG-517, a novel TRPV1 antagonist, from Amgen
Read More
SCH-697466: a novel gamma-secretase inhibitor profiled at the SfN meeting
Read More
Abbott and Icagen present a potent and selective Nav1.8 blocker with analgesic efficacy
Read More
Orphan drug designation for talactoferrin in renal cell carcinoma
Read More
Aricept approved for severe Alzheimer's disease
Read More
French approval for Loramyc for oropharyngeal candidiasis
Read More
Wyeth presents the neuroprotective effects of novel Src kinase inhibitor in stroke
Read More